Enbrel mechanism of action?

How does Enbrel work in the body?

Enbrel (etanercept) is a tumor necrosis factor (TNF) blocker. It works by acting like a decoy receptor for TNF-alpha (and also TNF-beta), binding to TNF molecules in the body so they can’t attach to TNF receptors on cell surfaces. That reduces inflammation and helps calm the immune system’s disease-driving activity in conditions such as rheumatoid arthritis and other inflammatory diseases [1].

Why does blocking TNF reduce inflammation?

TNF-alpha is a key signaling molecule in immune and inflammatory pathways. In many autoimmune diseases, TNF contributes to ongoing inflammation and tissue damage. By neutralizing TNF, Enbrel lowers downstream inflammatory signaling, which helps improve symptoms and slow disease processes [1].

Does Enbrel block all immune signals?

No. Enbrel specifically targets TNF signaling. It does not broadly suppress the entire immune system; its effect is aimed at preventing TNF from triggering its normal inflammatory pathways [1].

What does this mean for patients’ risks?

Because Enbrel reduces TNF-driven immune activity, it can increase susceptibility to certain infections. This is a known class effect for TNF blockers, since TNF plays an important role in immune defense, particularly against infections [1].

Sources

[1] https://www.drugs.com/monograph/enbrel.html